Clarivate launches $2.2B term loan refinancing; expects $800M-$900M goodwill impairment in Q4 2023

CLARIVATE PLC

Refinancing of 2026 Term Loan B with new $2.2B, 7-year facility maturing in 2031, subject to market conditions.
Expects non-cash goodwill impairment charge of $800M-$900M in Q4 2023 for IP and Life Sciences & Healthcare segments.
Impairment lowers GAAP net loss forecast but no impact on 2023 revenue, Adjusted EBITDA, or other non-GAAP guidance.
CFO states refinancing proactively extends debt maturities and improves financial flexibility.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.